In light of potential tariff threats from President Donald Trump, Pfizer Inc.’s (PFE.N) CEO Albert Bourla has suggested the possibility of shifting the company’s overseas manufacturing to its U.S. facilities.
Pfizer CEO Says Company May Shift Overseas Manufacturing To US Amid Looming Tariff Threats: ‘Will The Trump Administration Co-Invest’, Asks Analyst
